"BE BRAVE. TAKE RISKS. NOTHING CAN SUBSTITUTE EXPERIENCE." - PAULO COELHO
We have experienced the challenges of managing Life Sciences companies through all different stages and have experience from an entrepreneurial perspective as well as that from key stakeholders in the industry.
We understand the enormous potential but are also aware of the downsides of the different financing modalities and help you compensate for them. This allows you to gain full control over the complete value chain and optimize the potential of your company.
For our consultancy, we draw from our academic work on innovation as well as extensive business experience in the Life Sciences, providing you an evidence-based approach to innovation that allows you to help secure the future. The team of FFUND has more than 30 years of successful experience in (non) dilutive funding.
Linda van de Burgwal, MSC
E: linda . vandeburgwal [at] ffund.nl
Linda combines a background in life sciences with experience as entrepreneur, project manager and business developer. She is committed to transforming academic insights into practical contributions to innovation processes.
Judith Smit, PhD
E: judith . smit [at] ffund.nl
Judith is a dedicated life science specialist with extensive experience in building and leading successful public-private partnerships. She obtained her PhD in molecular biology at the Netherlands Cancer Institute and dedicates her knowledge of the biotechnology field to help projects, businesses and collaborative networks to develop their innovations into actual products for the society.
Henk Viëtor, MD, PHD
E: henk . vietor [at] ffund.nl
Henk is a medical doctor and scientist by training. He became involved in the industry in 2001 and co-founded of more than 15 life sciences companies. On several of these companies he was CEO. He secured more than 400 million euro in (non)-dilutive funding for his companies and third parties. Henk has been active in several public private partnerships (CTMM, TiPharma and Lygature).
Prof. Eric Claassen
E: eric . claassen [at] ffund.nl
Eric is 20% academic and 80% entrepreneur. He has co-founded more than 20 life sciences companies and is Chairman of the PAB of Pfizer Consumer Health, Chairman of the SAB of Christian Hansen A/S (Probiotics) and the SAB of Forbion life science venture capital. He was also the winner of the Dutch 1 million Euro NGI Valorisation Award for ‘Excellent deal making with Indust
Willem-Jan Keune, PhD
E: willemjan . keune [at] ffund.nl
Willem-Jan has a background as biomedical researcher, specialised in biochemistry, molecular and cell biology and structural biology. He performed his PhD studies at the Netherlands Cancer Institute (NKI) and the Cancer Research UK Manchester Institute after which he returned to Amsterdam to continue his academic career as a Postdoctoral researcher at the NKI.
At FFUND Willem-Jan combines his fascination for new developments and innovations in Health and life Sciences with a drive to help both academia and industry further in the R&D process.
Maurits van den Nieuwboer, PHD
E: maurits . vandennieuwboer [at] ffund.nl
Maurits has a background in biomedical sciences (immunology) and obtained his PhD at the Vrije Universiteit Amsterdam. His focus was on stimulating R&D in the field microbiota and probiotic .
He is an entrepreneurial consultant passionate about making an meaningful impact by accelerating innovation in the Health and Life Sciences.
Mima Malcicka, PhD
E: mima . malcicka [at] ffund.nl
Mima obtained her PhD degree in Life Sciences (Biology) during which she gained experience as an editor and a consultant in nutrition science.
She is enthusiastic about transferring academic knowledge of health and life sciences into practical perspectives for society.
Mark van der Waal, MSC
E: mark . vanderwaal [at] ffund.nl
Mark has a background in Biomedical Sciences and Health Technology Assessment (BSc, Radboudumc) as well as in Management and Entrepreneurship in the Life Sciences (MSc, Vrije Universiteit). As a PhD researcher, he specializes in the roles of intangible resources and IP rights in life sciences industries. Operationalizing these hidden assets to leverage their potential in innovation and stakeholder value creation is at the center of his interests.
Anne Neevel, MSC
E: anne . neevel [at] ffund.nl
Anne holds a Bachelor’s degree in Biomedical Sciences (BSc) and a Master’s degree in Management, Policy Analysis and Entrepreneurship in Health and Life Sciences (MSc). During her studies she became interested in complex challenges that hinder or delay the market introduction of safe and effective medicinal products. She is dedicated to accelerate innovation in the health and life sciences with a special interest in international public health
Eline Peeters, BSC
E: eline . peeters [at] ffund.nl
Eline holds a bachelor’s degree in Health Sciences and is currently finishing her 2-year Master’s specialization in Health and Life Sciences-based Management and Entrepreneurship at the Vrije Universiteit (VU) Amsterdam. Graduating with a focus on intellectual property management, she is committed to bringing innovative ideas further in the R&D process with the aim of enhancing impact.
Iman Schultz, PhD
E: iman . schultz [at] ffund.nl
Iman has a strong background in biomedical life sciences, trained in both The Netherlands and the US. He worked at InteRNA Technologies BV for more than 7 years, and obtained ample experience in lead discovery and preclinical development of anti-cancer therapeutics. Iman looks forward to advancing the Dutch life sciences industry in the broadest sense.
OUR Expert Partners
“GREAT THINGS IN BUSINESS ARE NEVER DONE BY ONE PERSON. THEY’RE DONE BY A TEAM OF PEOPLE.” – STEVE JOBS
Arjan is FFUND’s go-to fiscal advisor with ample experience in high-tech sectors, including the Life Sciences. Next to being a previous professional soccer player he has years of experience at one of the big four consultancy firms as tax advisor. Together with Christiaan and Pieter he is the driving force behind CCOUNT.
Christiaan is our dedicated partner for all accountancy-related questions. With over 12 years of experience at the big four level, he has gained all the experience needed to deliver lean solutions that help entrepreneurs become accountable and compliant. Together with Arjan and Pieter, he is the driving force behind CCOUNT.
Pieter provides fiscal advice to a broad range of clients, from private persons to listed companies. He has a broad knowledge base with a clear focus on the legal protection of his clients, as shown by his appeal procedures up to the High Council. Together with Arjan and Christiaan, he is the driving force behind CCOUNT.
Venture capital expert
Bart is our expert partner when it comes to securing venture capital. As one of the first bankers to invest in Dutch Life Sciences at the ABN AMRO Private Equity department, he has more than 20 years of experience in finance, executive management and investing in innovative Life Sciences companies. He was head of the Life Sciences Venture team at ABN AMRO, was investment manager of Forbion Capital Partners and has been board member and CFO of a number of companies that concluded a successful IPO.
Marcel is our expert partner for legal issues resulting from starting up, acquiring financing instruments, mergers and acquisitions. As a previous entrepreneur and investment manager with more than 20 years of experience as a corporate lawyer he combines a practical and pragmatic perspective with sound legal advice.
Carine van den Brink
Carine is our expert partner for all legal issues regarding intellectual property licensing, research and development driven contracts, pharmaceutical contracts and corporate law. She combines 25 years of legal experience in Life Sciences with a medical background and in-depth knowledge of the biotech and technology markets. She lectures at multiple universities, frequently functions as jury member for Life Sciences venture awards and is on the Board of HollandBio.
Winand is our expert partner when it comes to drafting patent applications. With more than 15 years experience as a patent attorney with a special focus on Life Sciences, Biotech and Molecular Biology, he has intimate knowledge of patent strategy development for large and medium-sized companies.